Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia
Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia have?
Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia published?
Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia has 2023 year in the ScholarIQ index.
What is the open-access status of Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia?
Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia has diamond oa status in the ScholarIQ index.
What is the DOI of Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia?
The DOI for Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia is on the source record.
What is the OpenAlex record for Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia?
The OpenAlex for Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia is on the source record.